Kim Cohee

Executive Director - Patient Advocacy Tenaya Therapeutics

Seminars

Wednesday 15th July 2026
Pediatric Gene Therapy Access: Communicating with Families, Managing Expectations & Supporting Early Expanded Access Requests
2:30 pm
  • Educating patients and families about the risks and benefits of gene therapy and the expanded access process
  • Communicating transparently when programs are early and pediatric data is limited
  • Working compliantly with patient advocacy groups, who are monitoring clinical trials and other potential pathways to treatment
  • Managing sensitive conversations around eligibility, timelines, and uncertainty in lifelimiting pediatric conditions
Kim Cohee, Executive Director, Patient Advocacy, Tenaya Therapeutics